rs150205851

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001286402.1(CIITA):​c.1432C>A​(p.Leu478Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000876 in 1,613,454 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L478L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0045 ( 8 hom., cov: 33)
Exomes 𝑓: 0.00050 ( 7 hom. )

Consequence

CIITA
NM_001286402.1 missense

Scores

1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.785

Publications

0 publications found
Variant links:
Genes affected
CIITA (HGNC:7067): (class II major histocompatibility complex transactivator) This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
CIITA Gene-Disease associations (from GenCC):
  • MHC class II deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004653871).
BP6
Variant 16-10906921-C-A is Benign according to our data. Variant chr16-10906921-C-A is described in ClinVar as Benign. ClinVar VariationId is 459192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0045 (686/152318) while in subpopulation AFR AF = 0.0159 (659/41574). AF 95% confidence interval is 0.0148. There are 8 homozygotes in GnomAd4. There are 312 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001286402.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CIITA
NM_000246.4
MANE Select
c.1429C>Ap.Leu477Ile
missense
Exon 11 of 20NP_000237.2
CIITA
NM_001286402.1
c.1432C>Ap.Leu478Ile
missense
Exon 11 of 20NP_001273331.1
CIITA
NM_001379332.1
c.1432C>Ap.Leu478Ile
missense
Exon 11 of 20NP_001366261.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CIITA
ENST00000324288.14
TSL:1 MANE Select
c.1429C>Ap.Leu477Ile
missense
Exon 11 of 20ENSP00000316328.8
CIITA
ENST00000381835.9
TSL:1
c.860-2062C>A
intron
N/AENSP00000371257.5
CIITA
ENST00000573309.5
TSL:1
n.1400C>A
non_coding_transcript_exon
Exon 10 of 10

Frequencies

GnomAD3 genomes
AF:
0.00449
AC:
683
AN:
152200
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0158
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00120
AC:
298
AN:
248950
AF XY:
0.000821
show subpopulations
Gnomad AFR exome
AF:
0.0159
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.000498
AC:
727
AN:
1461136
Hom.:
7
Cov.:
31
AF XY:
0.000450
AC XY:
327
AN XY:
726912
show subpopulations
African (AFR)
AF:
0.0171
AC:
573
AN:
33480
American (AMR)
AF:
0.00114
AC:
51
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52674
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1112008
Other (OTH)
AF:
0.00123
AC:
74
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00450
AC:
686
AN:
152318
Hom.:
8
Cov.:
33
AF XY:
0.00419
AC XY:
312
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0159
AC:
659
AN:
41574
American (AMR)
AF:
0.00118
AC:
18
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00156
Hom.:
3
Bravo
AF:
0.00501
ESP6500AA
AF:
0.0128
AC:
56
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00150
AC:
182
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
MHC class II deficiency (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
13
DANN
Uncertain
0.98
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-0.72
T
PhyloP100
0.79
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.52
N
REVEL
Benign
0.26
Sift
Benign
0.20
T
Sift4G
Benign
0.33
T
Vest4
0.16
MVP
0.76
MPC
0.24
ClinPred
0.012
T
GERP RS
0.55
gMVP
0.14
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150205851; hg19: chr16-11000778; COSMIC: COSV107405266; COSMIC: COSV107405266; API